Biohaven

Recent news

• Rating change
  Raymond James Maintains Biohaven(BHVN.US) With Buy Rating
  Market Newswire · 2026/9/10
• Rating change
  Analysts' Opinions Are Mixed on These Healthcare Stocks: Gossamer Bio (GOSS) and Biohaven Ltd. (BHVN)
  TipRanks · 2026/8/27
• Citi Maintains Biohaven(BHVN.US) With Buy Rating, Maintains Target Price $17
  Market Newswire · 2026/9/18
• BofA Securities Maintains Biohaven(BHVN.US) With Sell Rating, Maintains Target Price $11
  Market Newswire · 2026/8/27
• Rating change
  Analysts' Opinions Are Mixed on These Healthcare Stocks: Regeneron (REGN), Cytokinetics (CYTK) and Biohaven Ltd. (BHVN)
  TipRanks · 2026/9/10
• Rating change
  Analysts Are Bullish on Top Healthcare Stocks: Biohaven Ltd. (BHVN), Boston Scientific (BSX)
  TipRanks · 2026/9/14
• Company notice
  Biohaven: Biohaven Pharmaceutical Holding Company Ltd. - Anticipated Adjustment Option Symbol: BHVN New Symbol: To be determined
  OCC · 2022/9/13
• Rating change
  Analysts Are Bullish on These Healthcare Stocks: Globus Medical (GMED), Biohaven Ltd. (BHVN)
  TipRanks · 2026/8/28
• CCORF Maintains Biohaven(BHVN.US) With Buy Rating, Maintains Target Price $21
  Market Newswire · 2026/9/30
• Company notice
  Biohaven: Biohaven Pharmaceutical Holding Company Ltd. - Contract Adjustment Option Symbol: BHVN New Symbol: BHVN1
  OCC · 2022/10/3
• Rating change
  Analysts Offer Insights on Healthcare Companies: Airsculpt Technologies (AIRS), Biohaven Ltd. (BHVN) and Kalaris Therapeutics (KLRS)
  TipRanks · 2026/8/12
• J.P. Morgan Maintains Biohaven(BHVN.US) With Buy Rating
  Market Newswire · 2026/9/14
• Rating change
  Raymond James Maintains Biohaven(BHVN.US) With Buy Rating, Announces Target Price $30
  Market Newswire · 2026/8/26
• Rating change
  Analysts' Top Healthcare Picks: Molina Healthcare (MOH), Biohaven Ltd. (BHVN)
  TipRanks · 2026/8/27
• Rating change
  William Blair Maintains Biohaven(BHVN.US) With Hold Rating
  Market Newswire · 2026/9/10
• Rating change
  Piper Sandler Maintains Biohaven(BHVN.US) With Buy Rating, Maintains Target Price $30
  Market Newswire · 2026/8/17
• Rating change
  Morgan Stanley Maintains Biohaven(BHVN.US) With Buy Rating, Cuts Target Price to $18
  Market Newswire · 2026/8/12
• Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), AxoGen (AXGN) and Biohaven Ltd. (BHVN)
  TipRanks · 2026/9/30
• Rating change
  RBC Capital Downgrades Biohaven(BHVN.US) to Hold Rating, Cuts Target Price to $19
  Market Newswire · 2026/9/8
• Rating change
  A Quick Look at Today's Ratings for Biohaven(BHVN.US), With a Forecast Between $19 to $30
  Market Newswire · 2026/8/12

Headlines are aggregated automatically and are not independently verified or edited by our team.